ClinConnect ClinConnect Logo
Search / Trial NCT05390151

Laser Assisted Treatment of Fistula In Ano

Launched by UNIVERSITY HOSPITAL, ANTWERP · May 23, 2022

Trial Information

Current as of May 01, 2025

Recruiting

Keywords

Rectal, Advancement Flap Laser Assisted Fistula Closure Randomised Control Trial

ClinConnect Summary

This clinical trial is studying a new treatment for a condition called "fistula in ano," which is an abnormal connection between the rectum and the skin around the anus. The trial compares two different methods of closing these fistulas: one uses a laser to assist in the closure, and the other uses a surgical technique called a rectal advancement flap. The goal is to see which method works better for patients.

To be eligible for the trial, participants need to be at least 18 years old and have a specific type of fistula that affects more than one-third of the external anal sphincter. They should also have had a loose seton (a type of drainage tube) in place for at least two months. However, certain individuals, such as those with complex fistulas, certain diseases, or who are pregnant, cannot participate. If someone joins the study, they will receive one of the two treatments and will be monitored throughout the process to see how well the treatment works. This trial is currently looking for participants, so it could be a good opportunity for those who meet the criteria and are seeking relief from their condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with fistula involving more than one-third of the external anal sphincter
  • Single, continuous fistula tract at time of inclusion
  • Loose seton present in fistula tract for 2 months or more at time of inclusion
  • Age ≥ 18
  • Able to complete an informed written consent, understand its implications and contents, and participate in follow-up
  • Exclusion Criteria:
  • Fistula tract \< 1 cm
  • Complex fistula tract system (branching of fistula tract inside the sphincter complex)
  • Pregnancy
  • HIV-positive
  • Crohn´s disease, Ulcerative colitis
  • Fistula due to malignancy
  • Tuberculosis
  • Hidradenitis Suppurativa
  • No internal opening
  • Unable to undergo or contraindications to MRI

About University Hospital, Antwerp

University Hospital Antwerp is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital fosters a collaborative environment that integrates cutting-edge scientific inquiry with state-of-the-art medical practices. As a prominent sponsor of clinical trials, University Hospital Antwerp is committed to enhancing medical knowledge and improving treatment outcomes across a wide range of specialties, leveraging its expertise to contribute significantly to the global medical community.

Locations

Brussels, , Belgium

Hasselt, Limburg, Belgium

Edegem, Antwerpen, Belgium

Geel, Antwerpen, Belgium

Gent, Oost Vlaanderen, Belgium

Patients applied

0 patients applied

Trial Officials

Niels Komen, M.D. Phd

Study Chair

University Hospital, Antwerp

Sander Van Hoof, M.D.

Principal Investigator

University Hospital, Antwerp

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials